🔗 Share this article Social Media Content Creators Fueling Unofficial Trade for Unapproved Slimming Medication An underground market for unapproved weight-loss drugs is being driven by TikTok fitness influencers and sellers on communication apps, according to recent findings. Investigational Drug Gaining Traction Via Social Media Retatrutide, which remains in clinical trials, is being promoted by social media influencers for its alleged weight-reducing properties. Followers are urged to contact these accounts directly for supplier links, while also receiving promotional offers. Active Trade on Messaging Platforms Separately, a robust trade exists on messaging services, where groups with thousands of members share “before and after” images, administration instructions and claims of next-day British shipping. Vendors promote the substance there before redirecting customers to other platforms for transactions. Learning About Retatrutide This medication is an investigational injection developed by US drugmaker Eli Lilly. The drug affects three intestinal hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies suggest it could help individuals reduce up to 25% of their body weight. Referred to as the “triple G”, the substance is being hailed online as the successor to Ozempic. Medical Professionals Express Concerns However, physicians and pharmacists have cautions that the distribution of what remains an unlicensed medication in the UK is a cause for concern and could result in users administering products of unknown origin. Several experts stated the demand for retatrutide could be connected to the rising cost of licensed weight loss treatments such as Mounjaro. Regulatory Status and Enforcement Selling retatrutide on TikTok or messaging apps is illegal in the United Kingdom, as it is an unapproved drug that must not be promoted or distributed for personal consumption under the Human Medicines Regulations 2012. Several influencers attempt to sidestep the regulations by calling to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted substance, but promotion and distribution can still breach medicines, advertising, and customer regulations, potentially leading to penalties, legal action or prison. Platform Reaction and Material Elimination Based on TikTok, the service has taken down problematic material and banned related hashtags and query recommendations. The organization stated it was dedicated to maintaining the service secure and investing in strengthening enforcement strategies. Online Marketplace Activities Research also discovered groups with up to nine thousand participants selling the experimental drug using Telegram's built-in discovery tool, which functions like a online catalog. Typing “retatrutide” instantly displays channels with thousands of users, filled with images of slimming results, positive testimonials and step-by-step guides for preparing or administering at home. Within minutes of entering one group, a vendor posted contact information, where most transactions occur. The seller provided an instruction manual and promised shipping within two days. When questioned whether the product was genuine, one vendor said: “You can’t be sure.” Another shared a image of a alleged testing documentation. None inquired about body mass, health issues or past usage. Product Information and Pricing Within these communities, messages display black plastic packages with Royal Mail stickers, stating to contain new batches. One communication read: “It took eight of us to load them this morning.” Buyers can choose between dry substance containers, mixed at home with purified liquid, or ready-to-use pens typically priced at 160 pounds for 20mg. When asked how long a injector should be used, sellers give conflicting responses ranging from a few weeks to “depends on your body”. Service Moderation and Safety Actions A representative for Telegram stated it regularly moderated dangerous content on its platform including content that encouraged the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”. Medical Professional Cautions “Individuals are administering materials they can’t verify. Although the science behind this drug is valid, these digital products may not contain what they advertise,” said Jason Murphy, the head of pharmaceutical services at Chemist4U. Dr Crystal Wyllie of Asda Online Doctor linked the surge in demand to recent price rises for authorized weight-loss medications such as Mounjaro. “With prices increasing, individuals are using online platforms. But fake treatments are highly dangerous. You can’t be certain what’s inside or whether the conditions they were produced in was sterile,” she said. Her team has previously encountered individuals injured by personal administration from unverified sources. “We understand the disappointment, but purchasing from Telegram or communication platforms is gambling with your well-being,” stated Wyllie. “These substances could be contaminated or improperly measured.” Producer Position A representative from Eli Lilly stated retatrutide was in phase 3 research studies and had not been evaluated or approved by any regulatory agency globally. “Consequently at this time no one can sell [it] for human use,” they explained, adding that any product “falsely representing itself as a Lilly investigational substance not yet authorized … may subject patients to potentially significant medical dangers”.